Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballot

Showing results (211-220 of 248) with videos related to

Pageof 25
Sort By:
Cancers|June 28, 2023
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSCNesrine Mabrouk, Cindy Racoeur, Jingxuan Shan, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicenter cohort studyAgathe Sinnaeve, Brigitte Bader-Meunier, Anne Mirguet, et al.
Bulletin Du Cancer|May 9, 2026
[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)]Justine Nasone, Caroline Ballot, Ulrick Birba, et al.
Journal of Hepatology|December 17, 2011
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipientsMylène Sebagh, Didier Samuel, Teresa Maria Antonini, et al.
Bulletin Du Cancer|November 28, 2017
[Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Ibrahim Yakoub-Agha, Christophe Ferrand, Yves Chalandon, et al.
British Journal of Cancer|May 19, 2018
Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" projectGiuseppe Gullo, Naomi Walsh, David Fennelly, et al.
International Journal of Molecular Sciences|March 13, 2025
Genetic Variants Associated with Suspected Neonatal Hypoxic Ischaemic Encephalopathy: A Study in a South African ContextCaroline J Foden, Kevin Durant, Juanita Mellet, et al.
Pediatric Hematology and Oncology|January 20, 2023
SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South AfricaJennifer Geel, Marc Hendricks, Yasmin Goga, et al.
Orphanet Journal of Rare Diseases|March 28, 2013
Experimental designs for small randomised clinical trials: an algorithm for choiceCatherine Cornu, Behrouz Kassai, Roland Fisch, et al.
Bulletin Du Cancer|July 17, 2025
[End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)]Justine Nasone, Carina Alves Goncalves, Caroline Ballot, et al.
Pageof 25

Showing results (211-220 of 248) with videos related to

Sort By:
Pageof 25
Cancers|June 28, 2023
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSCNesrine Mabrouk, Cindy Racoeur, Jingxuan Shan, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicenter cohort studyAgathe Sinnaeve, Brigitte Bader-Meunier, Anne Mirguet, et al.
Bulletin Du Cancer|May 9, 2026
[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)]Justine Nasone, Caroline Ballot, Ulrick Birba, et al.
Journal of Hepatology|December 17, 2011
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipientsMylène Sebagh, Didier Samuel, Teresa Maria Antonini, et al.
Bulletin Du Cancer|November 28, 2017
[Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Ibrahim Yakoub-Agha, Christophe Ferrand, Yves Chalandon, et al.
British Journal of Cancer|May 19, 2018
Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" projectGiuseppe Gullo, Naomi Walsh, David Fennelly, et al.
International Journal of Molecular Sciences|March 13, 2025
Genetic Variants Associated with Suspected Neonatal Hypoxic Ischaemic Encephalopathy: A Study in a South African ContextCaroline J Foden, Kevin Durant, Juanita Mellet, et al.
Pediatric Hematology and Oncology|January 20, 2023
SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South AfricaJennifer Geel, Marc Hendricks, Yasmin Goga, et al.
Orphanet Journal of Rare Diseases|March 28, 2013
Experimental designs for small randomised clinical trials: an algorithm for choiceCatherine Cornu, Behrouz Kassai, Roland Fisch, et al.
Bulletin Du Cancer|July 17, 2025
[End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)]Justine Nasone, Carina Alves Goncalves, Caroline Ballot, et al.
Pageof 25